Merck


Organon Completes Alydia Health Acquisition

Women’s health company Organon (OGN), which was spun-off from Merck (MRK), has completed the acquisition of commercial-stage medical device company Alydia Health. The …

Nektar Posts Better-Than-Feared Quarterly Loss, Misses On Revenues

Nektar Therapeutics reported a better-than-expected loss in the fourth quarter but lagged analysts’ expectations for revenues. Shares of the biopharmaceutical company dropped almost …

Merck Inks Deal To Buy Pandion Therapeutics For $1.85B; Shares Skyrocket

Merck & Company agreed to snap up Pandion Therapeutics, a clinical-stage biotechnology company, in a deal worth $1.85 billion.

Merck Stops Covid-19 Vaccine Program Due To Disappointing Data

Merck & Co. has decided to stop the development of its two COVID-19 vaccine candidates following “inferior” immune responses.

Merck Snaps Up VelosBio In $2.75B Oncology Deal; Shares Rise

Merck & Co has entered into a definitive agreement to snap up all outstanding shares of VelosBio for $2.75 billion in cash, in …

Sanofi, Merck Join Forces On Ketruda, THOR-707 Combo In Cancer

Sanofi (SNYNF) has entered into an agreement with Merck to conduct a Phase 2 clinical trial to evaluate the safety, pharmacokinetics, and preliminary …

Pfizer or Merck: Which Pharma Stock Has More Upside Potential?

With COVID-19 cases continuing to surge, the attention of the whole world is currently on pharma companies developing potential treatments and vaccines for …

Merck Lifts 2020 Profit Outlook Driven By Cancer Drug Demand

Merck raised its 2020 adjusted profit outlook as the pharma giant is witnessing high demand for its cancer drug Keytruda as well as …

Merck Nabs Expanded Keytruda Label For Hodgkin Lymphoma

Merck (MRK) has announced that the U.S.

AstraZeneca-Merck’s Lynparza Gets Recommended By EU For Prostate, Ovarian Cancers

AstraZeneca announced that its Lynparza drug has been recommended for marketing authorization in the European Union (EU) for patients with metastatic prostate cancer (mCRPC) …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts